Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study

Abstract

Objectives

To determine the prevalence, determinants, and management of dyslipidaemia in the 25–74-year-old urban black population of Cape Town and examine the changes between 1990 and 2008/09 in the 25–64-year-old sample.

Methods

In 2008/09, a representative cross-sectional sample, stratified for age and sex, was randomly selected from the same townships sampled in 1990. Cardiovascular disease (CVD) risk factors were determined by questionnaires, clinical measurements, and fasting biochemical analyses. Survey logistic regression analysis assessed the determinants of raised low-density lipoprotein cholesterol (LDL-C).

Results

There were 1099 participants in 2008/09 (392 men and 707 women; response rate 86%). The prevalence of raised total cholesterol (TC), raised LDL-C, and reduced high-density lipoprotein cholesterol (HDL-C) were 25.2% (95% confidence interval, CI, 20.0–31.3), 37.8% (95% CI 32.5–43.4), and 55.2% (95% CI 49.9–60.4) in men and 23.1% (95% CI 20.0–26.5), 47.0% (95% CI 43.1–50.9), and 66.8% (95% CI 62.9–70.5) in women, respectively. Between 1990 and 2008/09, raised LDL-C and reduced HDL-C prevalence increased significantly with no change for raised TC. Among participants with raised LDL-C, only 2.6% were aware of their diagnosis, 2.7% were on treatment, and 1.5% had LDL-C <3 mmol/l. In the logistic model, increasing age (odds ratio, OR, 1.04, 95% CI 1.03–1.05; p < 0.001), rising body mass index (OR 1.03, 95% CI 1.01–1.05; p = 0.003), and fat intake ≥30% of diet (OR 1.37, 95% CI 1.02–1.85; p = 0.035) were significantly associated with LDL-C ≥3 mmol/l but not sex, physical activity, or urbanization.

Conclusions

The dyslipidaemia pattern in this population requires full lipogram screening in high-risk individuals and demands improved management using a total CVD risk approach.

Keywords

Black cholesterol epidemiology high-density lipoprotein cholesterol lipid management lipids low-density lipoprotein cholesterol South Africa triglycerides urban

Get full access to this article

View all access options for this article.

References

Norman

Bradshaw

Steyn

. Estimating the burden of disease attributable to high cholesterol in South Africa in 2000. S Afr Med J 2007; 97: 708–715.

Yusuf

Hawken

Ounpuu

. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–952.

Steyn

Damasceno

Lifestyle and related risk factors for chronic disease. In: Jamison

Feachem

Makgoba

(eds). The World Bank report: disease and mortality in sub-Saharan Africa, 2nd ed. Washington, DC: The World Bank, 2006, pp. 247–265.

Grundy

Benjamin

Burke

. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134–1146.

Steyn

Jooste

Bourne

. Risk factors for coronary heart disease in the black population of the Cape Peninsula. The BRISK study. S Afr Med J 1991; 79: 480–485.

Peer

Steyn

Lombard

. Rising diabetes prevalence among urban-dwelling black South Africans. PloS One 2012; 7: e43336–e43336.

World Health Organization. Department of Noncommunicable Diseases. Global Physical Activity Questionnaire and analysis guide 2002, Geneva: WHO, 2002.

Bonita R, deCourten M, Dwyer T, et al. Surveillance of risk factors for non-communicable disease: the WHO STEP-wise approach (2002). Available at: http://www.who.int/chp/steps/STEPS_Instrument_v2.1.pdf.

Ewing

. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252: 1905–1907.

10.

Alberti

Zimmet

Shaw

. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med 2006; 23: 469–480.

11.

World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation, Geneva: WHO, 1999.

12.

South African Medical Association and Lipid and Atherosclerosis Society of Southern Africa Working Group. Diagnosis, management and prevention of the common dyslipidaemias in South Africa – clinical guideline, 2000. S Afr Med J 2000; 90: 164–174, 176–178.

13.

Friedewald

Levy

Fredrickson

. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

14.

World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation, Geneva: WHO, 2000.

15.

Filmer

Pritchett

. Estimating wealth effects without expenditure data – or tears: an application to educational enrollments in states of India. Demography 2001; 38: 115–132.

16.

Oelofse

Jooste

Steyn

. The lipid and lipoprotein profile of the urban black South Africa population of the Cape Peninsula – the BRISK study. S Afr Med J 1996; 86: 162–166.

17.

Vorster

. The emergence of cardiovascular disease during urbanisation of Africans. Public Health Nutr 2002; 5: 239–243.

18.

Maritz

Dyslipidaemia in South Africa. In: Steyn

Fourie

Temple

(eds). Chronic diseases of lifestyle in South Africa: 1995–2005, technical report, Cape Town: South African Medical Research Council, 2006, pp. 97–108.

19.

Raal

. Questioning the importance of LDL cholesterol: don’t throw the baby out with the bathwater!. Cardiovasc J Afr 2008; 19: 63–64.

20.

Ramjeeth

Butkow

Raal

. The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not at Goal study (SA-NAG). Cardiovasc J Afr 2008; 19: 88–94.

21.

Sumner

Zhou

Doumatey

. Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West africans and African Americans with metabolic syndrome: implications for cardiovascular disease prevention. CVD Prev Control 2010; 5: 75–80.

22.

Hill

Darko

Seffah

. Health of urban Ghanaian women as identified by the Women’s Health Study of Accra. Int J Gynaecol Obstet 2007; 99: 150–156.

23.

Muhihi

Njelekela

Mpembeni

. Physical activity and cardiovascular disease risk factors among young and middle-aged men in urban Mwanza, Tanzania. Pan Afr Med J 2012; 11: 11–11.

24.

Chirovsky

Fedirko

Cui

. Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review. Eur J Cardiovasc Prev Rehabil 2009; 16: 404–423.

25.

Cui

Jousilahti

. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease. Eur J Prev Cardiol 2013; 20: 89–97.

26.

Christian

Bourgeois

Lowe

. Prevalence, clinical characteristics and treatment patterns of low high-density lipoprotein cholesterol in the US population: National Health and Nutrition Examination Survey 2005–2008. J Cardiovasc Med (Hagerstown) 2011; 12: 714–722.

27.

Guerra

Wang

Grundy

. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 1997; 94: 4532–4537.

28.

Bimenya

Okot

Nangosa

. Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda. Afr Health Sci 2006; 6: 139–144.

29.

Haslam

James

. Obesity. Lancet 2005; 366: 1197–1209.

30.

Vorster

Venter

Wissing

. The nutrition and health transition in the North West Province of South Africa: a review of the THUSA (Transition and Health during Urbanisation of South Africans) study. Public Health Nutr 2005; 8: 480–490.

31.

Johansson

Nilsson

Stegmayr

. Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden. Nutr J 2012; 11: 40–40.

32.

Huxley

Lewington

Clarke

. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med 2002; 2: 315–323.

33.

Ahmed

Blaha

Nasir

. Effects of physical activity on cardiovascular disease. Am J Cardiol 2012; 109: 288–295.

34.

Smith

Jr Jackson

Pearson

. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 2004; 109: 3112–3121.

35.

Bertolotti

Maurantonio

Gabbi

. Review article: hyperlipidaemia and cardiovascular risk. Aliment Pharmacol Ther 2005; 22(Suppl 2): 28–30.

36.

Klug

. South African dyslipidaemia guideline consensus statement. S Afr Med J 2012; 102: 178–187.

37.

Steyn

Fourie

Shepherd

. Detection and measurement of hypercholesterolaemia in South Africans attending general practitioners in private practice – the cholesterol monitor. S Afr Med J 1998; 88: 1569–1574.

38.

Raal

Schamroth

Blom

. CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia. Cardiovasc J Afr 2011; 22: 234–240.

39.

Dennison

Peer

Lombard

. Cardiovascular risk and comorbid conditions among Black South Africans with hypertension in public and private primary care settings: the HiHi study. Ethn Dis 2007; 17: 477–483.